APA (7th ed.) Citation

H, L., E, P., MTP, F., C, P., E, V., N, F., . . . A, V. (2026). Recombinant Protein Drugs: A 2025 Update. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 40(4), 673. https://doi.org/10.1007/s40259-026-00783-z

Chicago Style (17th ed.) Citation

H, López-Laguna, et al. "Recombinant Protein Drugs: A 2025 Update." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 40, no. 4 (2026): 673. https://doi.org/10.1007/s40259-026-00783-z.

MLA (9th ed.) Citation

H, López-Laguna, et al. "Recombinant Protein Drugs: A 2025 Update." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 40, no. 4, 2026, p. 673, https://doi.org/10.1007/s40259-026-00783-z.